Abstract
Objective To investigate the infection status and metallo-β-lactamase (MBL) production of multi-drug resistant Pseudomonas aeruginosa (MRPA) in community medical institutions.Methods A total of54 MRPA trains were isolated fron multiple community medical institutions in Guangzhou between January and December 2011.The drug-resislance to 11 types of antibioties,including imipenem,was tested by using MicroScan Walk Away 40S1 automatie bbaecteria identiffication and drug sensitivity testing system.The resistance of imipenem-sensitive and -resistant Pseudomonas aeruginosa to nine common antibioties was compared.Production of MBL in imipenem-resistant Pseudomonas aeruginosa was analyzed via modified three-dimensionalexperiment.Results Of 54 MRPA strains,29(53.7%) were resistant to imipenem.There were a total of 9 imipenem-resistant Pseudomonas aeruginosa strains (9/29,31.0% ) that produced MBL,as revealed by three-dimensional experiment.lmipenem-resistant Pseudomonas aeruginosa yielded higher resistance rate to seven types of common antibiotics (ceftazidime:65.5% vs 36.0% ; cefotaxime:89.7% vs 44.0% ; ceftriaxone:100.0% vs 52.0%; aztreonam:72.4% vs 36.0%; ofloxacin:70.0% vs 32.0%; piperacillin-tazobactam:58.6% vs 16.0% ;amikaein:62.1% vs 32.0%,all P<0.05) as compared with imipenem-sensitive Pseudomonas aeruginosa.Conclusion The ratio of MBL-production from clinical isolated MRPA is higher in community medical institutions. Key words: beta-Lactamases; Pseudomonas aeruginosa; Imipenem; Drug resistance, multiple
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.